Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusa Raya Cipta Tbk. (NRCA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Nusa Raya Cipta Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Nusa Raya Cipta Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusa Raya Cipta Tbk. trades at Rp555 (market cap 1.39T, 4.72M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Nusa Raya Cipta Tbk. is far larger — about 8.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Nusa Raya Cipta Tbk. is more actively traded (4.72M versus 324K). Which is the better fit depends on your goals.

NRCAOBAT
Market Cap
1.39T166.01B
Volume
4.72M324K
Lot
47.24K3.24K
Turnover
2.56B77.68M
Average Price
541.98239.75
Value
2.56B77.68M
Indicative Equilibrium Price
555240
Indicative Equilibrium Volume
2701

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NRCA
View details
OBAT
View details

About Nusa Raya Cipta Tbk.

PT Nusa Raya Cipta Tbk (the Company) was establised based on notarial deed No. 134 of Ny Kartini Muljadi, SH., dated September 17, 1975.

Read more on NRCA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT